These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 366165)

  • 21. Clearance of falciparum parasitaemia with a single dose sulfadoxine-pyrimethamine in Vientiane, Laos.
    Tawil NA
    Southeast Asian J Trop Med Public Health; 1978 Sep; 9(3):409-13. PubMed ID: 373131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic efficacy of chloroquine and sulfadoxine/pyrimethamine against Plasmodium falciparum infection in Somalia.
    Warsame M; Abdillahi A; Duale ON; Ismail AN; Hassan AM; Mohamed A; Warsame A
    Bull World Health Organ; 2002; 80(9):704-8. PubMed ID: 12378287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of Plasmodium falciparum infection resistant to chloroquine.
    Assefa T
    Ethiop Med J; 1987 Oct; 25(4):209-10. PubMed ID: 3311731
    [No Abstract]   [Full Text] [Related]  

  • 24. Malaria chemoprophylaxis--which drug?
    Biddulph J
    P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malaria prevention with Fansidar].
    Wiedermann G; Stemberger H; Leimer R
    MMW Munch Med Wochenschr; 1983 Mar; 125(11):207-9. PubMed ID: 6405214
    [No Abstract]   [Full Text] [Related]  

  • 26. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of vivax malaria with a single dose of sulphadoxine and pyrimethamine (Fansidar).
    Ponnampalan JT; Frank HA
    Singapore Med J; 1983 Apr; 24(2):104-8. PubMed ID: 6351261
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan.
    Salah MT; Mohammed MM; Himeidan YE; Malik EM; Elbashir MI; Adam I
    Saudi Med J; 2005 Jan; 26(1):147-8. PubMed ID: 15756376
    [No Abstract]   [Full Text] [Related]  

  • 30. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
    Turner GD
    Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
    [No Abstract]   [Full Text] [Related]  

  • 31. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children of Papua New Guinea. II. Plasmodium vivax.
    Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
    Am J Trop Med Hyg; 1982 Jan; 31(1):10-3. PubMed ID: 7036765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
    Vestergaard Olsen V
    Ugeskr Laeger; 1983 Mar; 145(10):751. PubMed ID: 6344376
    [No Abstract]   [Full Text] [Related]  

  • 33. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
    JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409
    [No Abstract]   [Full Text] [Related]  

  • 34. Malaria suppression and prophylaxis on a Malaysian rubber estate: sulformethoxine-pyrimethamine single monthly dose vs chloroquine single weekly dose.
    O'Holohan DR; Hugoe-Matthews J
    Southeast Asian J Trop Med Public Health; 1971 Jun; 2(2):164-8. PubMed ID: 4944641
    [No Abstract]   [Full Text] [Related]  

  • 35. Compared response to chloroquine, fansidar, quinine, and quinidine slow release of infections with Plasmodium falciparum in the Kivu region of Zaire.
    Delacollette C; Cibanguka J; Buregea H; Nkera J
    Acta Leiden; 1987; 55():159-62. PubMed ID: 3321832
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C; Kibbler CC; Ellis CJ; Mtawali CV
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique].
    Dinis DV; Schapira A
    Bull Soc Pathol Exot; 1990; 83(4):521-7; discussion 528. PubMed ID: 2286005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malaria in 1985: new recommendations].
    Hemmer R
    Bull Soc Sci Med Grand Duche Luxemb; 1985; 122(1):19-20. PubMed ID: 4042266
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo assessment of the sensitivity of Plasmodium falciparum to sulphadoxine/pyrimethamine combination (Fansidar) in six localities in Tanzania where chloroquine-resistant P. falciparum has been detected.
    Kilimali VA; Mkufya AR
    Trans R Soc Trop Med Hyg; 1985; 79(4):482-3. PubMed ID: 3909553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.